v3.25.1
Condensed Balance Sheets - USD ($)
Mar. 31, 2025
Dec. 31, 2024
Current assets:    
Cash and cash equivalents $ 73,441,391 $ 56,490,579
Marketable securities 19,738,900 41,052,949
Prepaid research and development 52,475 81,308
Prepaid expenses and other current assets 931,992 826,473
Total current assets 94,164,758 98,451,309
Equipment and improvements, net 47,845 47,100
Right-of-use asset 68,719 101,437
Total assets 94,281,322 98,599,846
Current liabilities:    
Accounts payable 1,692,051 943,019
Lease obligation, current 74,772 110,517
Accrued expenses and other current liabilities 3,513,248 2,680,030
Contingent consideration liability 3,270,579 0
Total current liabilities 8,550,650 3,733,566
Total liabilities 8,550,650 3,733,566
Commitments and contingencies (see Note 15)
Stockholders’ equity:    
Preferred stock, $0.001 par value; 10,000,000 shares authorized; 0 shares issued and outstanding at March 31, 2025 and December 31, 2024 0 0
Common stock, $0.001 par value; 500,000,000 and 100,000,000 shares authorized; 74,341,540 and 69,362,439 shares issued and outstanding (including 4,149,252 and 0 contingently issuable shares - see Note 10) at March 31, 2025 and December 31, 2024, respectively 74,341 69,362
Additional paid-in capital 193,756,644 189,254,777
Accumulated other comprehensive loss (967) (37,248)
Accumulated deficit (108,099,346) (94,420,611)
Total stockholders' equity 85,730,672 94,866,280
Total liabilities and stockholders' equity $ 94,281,322 $ 98,599,846

Source